Active Ingredient(s): Strontium-89 Chloride
FDA Approved: * June 18, 1993
Pharm Company: * GE HEALTHCARE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Metastron Overview

Strontium is the chemical element with the symbolSr and atomic number38. An alkaline earth metal, strontium is a soft silver-white yellowish metallic element that is highly chemically reactive. The metal forms a dark oxide layer when it is exposed to air. Strontium has physical and chemical properties similar to those of its two vertical neighbors in the periodic table, calcium and barium. It occurs naturally mainly in the minerals celestine and strontianite, and is mostly mined from these. B...

Read more Metastron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Metastron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Strontium-89 Chloride
  • Injection: 1mCi/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Metastron: (1 result)

Sorted by National Drug Code
  • 17156-524 Metastron 1 mci/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Medi-physics Inc.

Other drugs which contain Strontium-89 Chloride or a similar ingredient: (2 results)